Patent Assignment
Reel/Frame 051644/0367
Assignment of Assignor's Interest
Recorded: 2020-01-28
Pages: 4
Assignor
MOSS, JONATHAN
Executed: 2015-11-04
Assignee
THE UNIVERSITY OF CHICAGO
5801 S. ELLIS AVENUE, CHICAGO, ILLINOIS, 60637
Covered Property
(1)
Use of Methylnaltrexone to Attenuate Tumor Progression
Application:
16/667,300 →
Publication:
US 2020/0163958
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 28, 2020
From: JOHNSON, LORIN K.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 051644/0430 →
Intellectual Property Security Agreement
Feb 4, 2020
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; DOW PHARMACEUTICAL SCIENCES, INC.; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 051797/0416 →
Intellectual Property Security Agreement
Feb 4, 2020
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; DOW PHARMACEUTICAL SCIENCES, INC.; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT FOR THE NOTEHOLDER SECURED PARTIES
Reel/Frame 051797/0491 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →